让学生参与药物遗传学:使用PharmGKB网站的患者案例研究
Andrea M Mosquera1,2, Lauren M Aleksunes1,2,3
1Department of Pharmacology and Toxicology, Rutgers University, Ernest Mario School of Pharmacy, Piscataway, NJ.
CourseSource
|July 21, 2023
概括
这项研究开发了一个关于药物遗传学的交互课程,使用PharmGKB资源指导药物处方. 该活动成功地向学生教授了细胞P450 (CYP) 酶的遗传变异如何影响药物反应和剂量.
科学领域:
- 药物基因组学 药物基因组学
- 医学教育 医学教育
- 药物新陈代谢 药物新陈代谢
背景情况:
- 细胞染色体P450 (CYP) 酶对于药物的疗效和毒性至关重要.
- 在CYP酶的遗传变异显著影响患者对药物的反应,并可能导致不良反应.
- 该PharmGKB数据库提供了基本的药物基因组数据和临床指南.
研究的目的:
- 创建一个互动的,基于案例的教育活动,展示药物处方中的药物遗传学.
- 教学生如何利用药物遗传学原理来优化药物治疗决策.
主要方法:
- 为71名学生进行了为期两小时的在线互动课程.
- 该会议包括关于药物遗传学的讲座,PharmGKB网站的介绍和案例研究.
- 学生在小组中使用PharmGKB来分析患者病例并推药物治疗.
主要成果:
- 患者病例涵盖了CYP酶 (CYP2C19,CYP2D6,CYP3A5,CYP2B6) 的遗传变异,影响了抑郁症,疼痛,器官移植和病毒感染的治疗.
- 学生成功地使用PharmGKB回答问题并制定治疗计划.
- 课前/课后的评估和反表明药物遗传学原则的有效学习.
结论:
- 交互式,以小组为基础的学习方法是有效的药物遗传学教学.
- 这项活动成功地将学生与在线药物遗传学资源联系起来,以了解药物剂量.
- 药物遗传学原则可以有效地纳入医学教育,以改善处方实践.
相关概念视频
01:12Analysis of Population Pharmacokinetic Data
297
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
297
01:28Biopharmaceutics and Pharmacokinetics: Overview
2.1K
Understanding drugs, drug products, and their performance in pharmaceutical science is pivotal. Drugs, whether simple molecules or complex compounds, are designed to interact with the body's biological systems to diagnose, treat, or prevent diseases. Drug products include various delivery systems such as tablets, capsules, injections, and inhalers. The performance of these drug products is gauged by their ability to deliver the active ingredient to the desired site of action at the...
2.1K
01:20Pharmacokinetic Models: Overview
794
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
794
01:15Model Approaches for Pharmacokinetic Data: Physiological Models
78
Physiological models in pharmacokinetics are instrumental in understanding the distribution and elimination of drugs within the body. These models describe the drug concentration within target organs, influenced by factors such as drug uptake, tissue volume, and blood flow. Drug uptake is governed by the partition coefficient, which signifies the drug concentration ratio in tissue to that in the blood. The blood flow rate to a specific tissue is expressed as Qt, and the rate of change in tissue...
78
01:27Nonlinear Pharmacokinetics: Role of Transporters
73
A drug's nonlinear kinetics can be influenced by a diverse range of transporter proteins that serve as crucial players in drug distribution. These transporters, found within cells, can enhance or reduce local drug concentrations by facilitating the influx or efflux of drugs. For instance, the expression of xenobiotic transporters can be influenced by factors such as age and gender, potentially impacting the linearity of drug response.
Polymorphisms occurring in drug transporters can alter...
Polymorphisms occurring in drug transporters can alter...
73
01:07Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance
61
Drug transporters are critical in drug absorption, distribution, and excretion processes. They should be included in physiological-based pharmacokinetic (PBPK) models, which help predict human drug disposition. However, predicting this is challenging during drug development, especially when liver transport is involved. However, with a realistic representation of body transport processes, an accurate model may be possible.
A recent model describes pravastatin's hepatobiliary excretion,...
A recent model describes pravastatin's hepatobiliary excretion,...
61